Gabapentin Dementia Lawsuit in Kentucky - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Kentucky is a focal jurisdiction for gabapentin litigation, combining some of the highest per-capita prescribing rates in the nation with early regulatory action that acknowledged the drug's dangers. Kentucky classified gabapentin as a Schedule V controlled substance in 2017 — one of the first states to do so — after the state's KASPER prescription monitoring program revealed alarming co-prescribing patterns with opioids. Eastern Kentucky's Appalachian communities bore the brunt of the opioid crisis and subsequently received massive gabapentin prescribing as physicians sought alternatives, creating a population with extended high-dose exposure and minimal cognitive monitoring. The state's aggressive plaintiff bar and experienced mass tort judges, particularly in Jefferson County (Louisville), make Kentucky one of the strongest jurisdictions for gabapentin cognitive decline claims. Kentucky's data showing gabapentin was the most commonly identified drug in coroner reports ahead of any single opioid underscores the scope of the state's gabapentin crisis.

Written By

People's Justice Legal Research Team

Statute of Limitations

Kentucky: 1 year for personal injury (KRS § 413.140(1)(a)). Discovery rule applies — limitations begin when the plaintiff discovers or should have discovered the injury and its cause. Kentucky's short SOL makes prompt legal consultation critical after discovering the gabapentin-dementia connection.

1 year from discovery of injury

Filing Venue

Where to File in Kentucky

Kentucky gabapentin cases may be filed in the Eastern District (Lexington, Covington, Pikeville) or Western District (Louisville, Bowling Green). Jefferson County Circuit Court in Louisville is the primary state court venue for mass tort pharmaceutical litigation. Kentucky follows pure comparative fault. The state does not cap compensatory damages in product liability cases. Kentucky's 1-year SOL is the shortest statutory period among states — claimants must act immediately upon discovering the gabapentin connection. The KASPER PDMP provides comprehensive gabapentin prescribing data since 2017 scheduling.

Kentucky Data

Exposure in Kentucky

Source: IQVIA / KY KASPER PDMP data

Source: Kentucky Board of Pharmacy / KY Office of Drug Control Policy

Source: Kentucky Office of the State Medical Examiner

FAQ

Frequently Asked Questions

See details below.

Back to Gabapentin Dementia Lawsuit Lawsuit Overview